Popular Articles
Benefits Of Grapefruit

Revised Vienna Classification For Diagnosing Colorectal Epithelial Neoplasias
Considerable discrepancies have been reported between diagnoses of colorectal epithelial neoplastic lesions made by Western and Japanese pathologists from endoscopic cold biopsies and resected specimens of the same lesions
generic viagra online
3-D Structures With 'DNA Origami'
By combining the art of origami with nanotechnology, Dana-Farber Cancer Institute researchers have folded sheets of DNA into multilayered objects with dimensions thousands of times smaller than the thickness of a human hair. These tiny structures could be forerunners of custom-made biomedical nanodevices such as "smart" delivery vehicles that would sneak drugs into patients" cells, where they would dump their cargo on a specific molecular target.
News of the day
GOP House Members Send Obama Letter Asking Him To Reinstate 'Conscience' Rule
House GOP members on Tuesday sent a letter to President Obama praising him for saying that he wants to "honor the conscience of those who disagree with abortion" during his commencement address at the University of Notre Dame last weekend, The Hill reports. The Republican lawmakers -- Reps. James Sensenbrenner (Wis.), Chris Smith (N.J.) and John Fleming (La.) -- said Obama"s speech indicated to them that he would reinstate the HHS provider "conscience" rule, which expanded the ability of health workers to refuse to provide services or information they objected to on moral or religious grounds and prohibited federal funding for health entities that do not comply.In March, Obama began the process for rescinding the Bush-era rule, and it is currently undergoing a White House review. In the letter, the representatives said that they "agree with [Obama] that pro-life health care providers should have the right to refuse to participate in procedures that they find morally reprehensible." Smith said he has "renewed hope, hopefully not false" that Obama will "completely forgo the rescinding of this rule" after his remarks during Sunday"s speech (Hooper, The Hill, 5/19).
Health Insurance

The Endocrine Society Responds To Recent Insulin Glargine (Lantus(R)) Study With Recommendations For Patients And Physicians

Five articles recently posted online in the medical journal Diabetologia studied the possible connection between the use of insulin glargine (Lantus®) and the development of cancer. While one of these studies suggested an increased risk of cancer, the other four did not come to the same conclusion. Taken together, the results of all these studies do not conclusively show that insulin glargine causes cancer or is otherwise harmful to a patient"s overall health. In terms of clinical practice, there does not appear to be sufficient evidence to recommend against the use of insulin glargine. The Society anticipates that as medical experts perform new studies, the potential risks and benefits of insulin glargine will become more clearly defined. To address concerns about the potential relationship between insulin glargine and cancer, the Society has issued two statements: one for patients and the other for physicians. In the statements, available online at http://www.endo-society.org/advocacy/policy/index.cfm, the Society provides a summary of the studies published in Diabetologia and offers recommendations regarding treatment of diabetic patients. The Society recommends that patients continue with their insulin regimen and discuss with their physicians the reasons why a particular insulin treatment was prescribed. In addition, patients with diabetes, like all other individuals, should make sure that they follow recommended procedures for screening and early detection of cancer, such as periodic mammography and colonoscopy. The Society recommends that physicians continue to individualize their therapy based on a patient"s situation and encourage their patients to follow current recommendations for screening tests for cancer and avoid dangerous habits, such as smoking. The Endocrine Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):